Richard Eric Schlumpf

This inventor holds 8 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Sustain Holdings, LLC. Active years: 2020-2026.

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 10(Granted Patents)

Company Filing History:

8 out of 8

Sustain Holdings, LLC

patents

Years Active: 2020-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551525 - COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF (2026-02-17),

2. 12419936 - Collagen peptide-based medicament compositions and devices and methods of production and use thereof (2025-09-23),

3. 12280086 - Collagen peptide-based medicament compositions and devices and methods of production and use thereof (2025-04-21),

4. 11684651 - Collagen peptide-based medicament compositions and devices and methods of production and use thereof (2023-06-27),

5. 11433112 - Collagen peptide-based medicament compositions and devices and methods of production and use thereof (2022-09-06),

6. 11426440 - Collagen peptide-based medicament compositions and devices and methods of production and use thereof (2022-08-30),

7. 11389513 - Collagen peptide-based medicament compositions and devices and methods of production and use thereof (2022-07-19),

8. 10632168 - Collagen peptide-based medicament compositions and devices and methods of production and use thereof (2020-04-28),

Title: Richard Eric Schlumpf: Innovator in Medicinal Chemistry

Introduction

Richard Eric Schlumpf is a notable inventor based in Stuart, FL (US). He has made significant contributions to the fields of medicinal chemistry, biotechnology, and pharmaceuticals. With a total of 8 patents to his name, Schlumpf continues to push the boundaries of innovation in healthcare.

Latest Patents

One of his latest patents is titled "Collagen Peptide-Based Medicament Compositions and Devices and Methods of Production and Use Thereof." This invention provides compositions that include one or more collagen mimetic peptides, which may be attached to therapeutic or imaging compounds. The primary focus of this invention is to treat, prevent, ameliorate, cure, and diagnose various diseases and physical disorders in both humans and veterinary animals. These include anterior and posterior segment ocular diseases, paraocular and extraocular diseases, and nerve or nervous system disorders. The invention also encompasses medical devices that utilize these compositions, along with methods for their production and application.

Career Highlights

Richard Eric Schlumpf is currently associated with Sustain Holdings, LLC, where he applies his expertise in developing innovative solutions in the medical field. His work has been instrumental in advancing therapeutic options for various health conditions.

Collaborations

Schlumpf has collaborated with notable professionals in his field, including Shawn A Delorey and Robert Baratta. These partnerships have contributed to the successful development of his innovative projects.

Conclusion

Richard Eric Schlumpf stands out as a prominent inventor in the realm of medicinal chemistry, with a focus on collagen peptide-based therapies. His contributions are paving the way for advancements in treating complex health issues.